Posts

Psychedelic Business Spotlight: October 8, 2021

Psychedelic Business Spotlight: October 8, 2021

,
This week in psychedelic business news: Enveric Biosciences uses AI to identify viable psychedelic drug candidates; Novamind launches end-of-life palliative care program; and PharmaTher tests ketamine to treat...

Interview with Evan Levine, PsyBio Therapeutics

In this episode of the Psychedelic Spotlight podcast, we spotlight Evan Levine, Chairman & CEO of PsyBio Therapeutics, an intellectual property driven biotechnology company developing novel formulations of psychoactive...
Why PsyBio Is Using Biosynthetic Psilocybin, Not Magic Mushrooms, to Build Better Therapeutics

Why PsyBio Is Using Biosynthetic Psilocybin, Not Mushrooms, to Build Better Therapeutics

"A mushroom is not a pharmaceutical product," CEO Evan Levine stresses, and explains why his company's method of biologically engineering psilocybin is "cheaper, faster, greener."
Psychedelics Companies PsyBio Therapeutics and Silo Wellness Start Trading on the OTCQB Venture Market

Psychedelics Companies PsyBio Therapeutics and Silo Wellness Start Trading on the OTCQB Venture Market

The OTCQB is a middle-tier market for entrepreneurial and development stage American and international companies.